Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Søren Lund Kristensen(University of Glasgow), John J.V. McMurray(Western Infirmary)
Cited by 1,589
Related Papers
Economics of Chronic Heart Failure
|European Journal of Heart Failure|2001|404
Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF
|JACC Heart Failure|2022|13